Source: Stoklund Dittlau, K. et al., Generation of Human Motor Units with Functional Neuromuscular Junctions in Microfluidic Devices. J. Vis. Exp. (2021)
The video demonstrates the formation of neuromuscular junctions using a microfluidic device. Neural precursor cells and muscle progenitor cells are seeded into different wells within the device and left to mature into motor neurons and myotubes, respectively. The creation of a volume and chemical gradient leads to the development of active neuromuscular junctions.
All procedures involving sample collection have been performed in accordance with the institute's IRB guidelines.
All reagents and equipment used in this protocol are listed in the Table of Materials and should be used sterile. Media should be heated to room temperature (RT) before use unless otherwise specified. For an overview of the co-culture protocol, please see Figure 1.
1. Differentiation of motor neuron progenitors from induced pluripotent stem cells (iPSCs)
2. Derivation and maintenance of human mesoangioblast (MABs)
NOTE: MABs are vessel-associated mesenchymal stem cells, which in this case have been harvested from biopsies obtained from a 58-year-old healthy donor. Alternative commercial sources are available. The protocol to obtain MABs is briefly explained. For further information, refer to the detailed protocol. All MAB media should be heated to 37 °C before use.
3. Preparation of pre-assembled microfluidic devices – Day 9
NOTE: The protocol is adapted from the microfluidic device manufacturer's neuron device protocol and has been adjusted for the use of both pre-assembled and silicone devices. Here, pre-assembled devices are used for immunocytochemistry (ICC) and live-cell calcium transient recordings, while silicone devices are used for scanning electron microscopy (SEM). The timeline of the protocol follows the timeline for the motor neuron differentiation protocol.
4. Plating of NPCs in microfluidic devices – Day 10
NOTE: According to the motor neuron differentiation protocol, plating of day 10 NPCs occurs on a Thursday.
5. Plating of MAB in microfluidic devices – Day 17
6. Implementation of a volumetric and chemotactic gradient to promote the growth of motor neuron neurites towards the MAB compartment
Table 1: MAB growth medium. Medium can last 2 weeks at 4 °C. bFGF is added fresh on the day of use.
Reagent | Stock concentration | Final concentration |
IMDM | 1x | 80% |
Fetal bovine serum | 15% | |
Penicillin/Streptomycin | 5000 U/mL | 0.5% |
L-glutamine | 50x | 1% |
Sodium pyruvate | 100 mM | 1% |
Non-essential amino acids | 100x | 1% |
Insulin transferrin selenium | 100x | 1% |
bFGF (added fresh) | 50 μg/mL | 5 ng/mL |
Table 2: Motor neuron basal medium. Medium can last 4 weeks at 4 °C.
Reagent | Stock concentration | Final concentration |
DMEM/F12 | 50% | |
Neurobasal medium | 50% | |
Penicillin/Streptomycin | 5000 U/mL | 1% |
L-glutamine | 50x | 0.5 % |
N-2 supplement | 100x | 1% |
B-27 without vitamin A | 50x | 2% |
β-mercaptoethanol | 50 mM | 0.1% |
Ascorbic acid | 200 μM | 0.5 μM |
Table 3: Motor neuron medium supplements. Supplements are added fresh on the day of use to the motor neuron basal medium.
Day | Reagent | Stock concentration | Final concentration | Compartment |
Day 10/11 | Smoothened agonist | 10 mM | 500 nM | Both |
Retinoic acid | 1 mM | 0.1 μM | ||
DAPT | 100 mM | 10 μM | ||
BDNF | 0.1 mg/mL | 10 ng/mL | ||
GDNF | 0.1 mg/mL | 10 ng/mL | ||
Day 14 | DAPT | 100 mM | 20 μM | Both |
BDNF | 0.1 mg/mL | 10 ng/mL | ||
GDNF | 0.1 mg/mL | 10 ng/mL | ||
Day 16 | DAPT | 100 mM | 20 μM | Both |
BDNF | 0.1 mg/mL | 10 ng/mL | ||
GDNF | 0.1 mg/mL | 10 ng/mL | ||
CNTF | 0.1 mg/mL | 10 ng/mL | ||
Day 18 | BDNF | 0.1 mg/mL | 10 ng/mL | Motor neuron |
GDNF | 0.1 mg/mL | 10 ng/mL | ||
CNTF | 0.1 mg/mL | 10 ng/mL | ||
Day 21+ | BDNF | 0.1 mg/mL | 30 ng/mL | Myotube |
GDNF | 0.1 mg/mL | 30 ng/mL | ||
CNTF | 0.1 mg/mL | 30 ng/mL | ||
Agrin | 50 μg/mL | 0,01 μg/mL | ||
Laminin | 1 mg/mL | 20 μg/mL | ||
Day 21+ | No supplements | Motor neuron |
Table 4: MAB differentiation medium. Medium can last 2 weeks at 4 °C. Agrin is added fresh on the day of use.
Day | Reagent | Stock concentration | Final concentration | Compartment |
Day 18 | DMEM/F12 | 97% | MAB | |
Sodium pyruvate | 100 mM | 1% | ||
Horse serum | 2% | |||
Agrin | 50 μg/mL | 0.01 μg/mL |
Figure 1: Schematic overview of the motor unit protocol in microfluidic devices. Differentiation timeline and co-culture overview from day 0 to day 28 according to the timeline of the motor neuron differentiation protocol. Motor neuron differentiation from iPSCs is initiated at day 0 and performed as stated previously for the following 10 days. On day 9, the device is sterilized and coated with PLO-laminin. MABs are thawed for expansion in T75 flasks. On day 10, the motor neuron-NPCs are plated in both wells and the channel of one compartment (light grey) of the device, where their differentiation into motor neurons is continued for a week. MABs are plated in both wells and the channel of the opposite compartment (dark grey) on day 17. On day 18, MABs differentiation into myotubes is begun. On day 21, a volumetric and chemotactic gradient is established to promote motor neuron-neurite polarization through the microgrooves of the device. The motor neuron compartment received 100 µL/well of motor neuron basal medium without growth factors (light green compartment), while the myotube compartment received 200 µL/well of motor neuron basal medium with 30 ng/mL of growth factors (dark green compartment) (Table 2 and Table 3). The culture is continued with the volumetric and chemotactic gradient for an additional 7 days until analysis on day 28. Bright-field images show cell morphology at day 0, day 11, day 18, and day 28 cultured in pre-assembled microfluidic devices. Scale bar, 100 µm.
The authors have nothing to disclose.
Acetic Acid | CHEM-Lab NV | CL00.0116.1000 | Coating component. H226, H314. P280 |
Agrin (recombinant human protein) | R&D systems | 6624-AG-050 | Media supplement |
Ascorbic acid | Sigma | A4403 | Media component |
βIII-tubulin (Tubulin) | Abcam | ab7751 | Antibody (1:500) |
β-mercaptoethanol | Thermo Fisher Scientific | 31350010 | Media component. H317. P280. |
B-27 without vitamin A | Thermo Fisher Scientific | 12587-010 | Media component |
BDNF (brain-derived neurotrophic factor) | Peprotech | 450-02B | Growth factor |
bFGF (recombinant human basic fibroblast growth factor) | Peprotech | 100-18B | Growth factor |
Collagen from calfskin | Thermo Fisher Scientific | 17104019 | Coating component |
CNTF (ciliary neurotrophic factor) | Peprotech | 450-13B | Growth factor |
DAPT | Tocris Bioscience | 2634 | Media supplement |
DMEM/F12 | Thermo Fisher Scientific | 11330032 | Media component |
DMSO | Sigma | D2650-100ML | Cryopreservation component. H315, H319, H335. P280. |
Dulbecco's phosphate-buffered saline (DPBS) | Thermo Fisher Scientific | 14190250 | no calcium, no magnesium |
Ethanol | VWR | 20.821.296 | Sterilization. H225. P280 |
Fetal bovine serum | Thermo Fisher Scientific | 10270106 | Media component |
Fluorescence Mounting Medium | Dako | S3023 | Immunocytochemistry component |
GDNF (glial cell line-derived neurotrophic factor) | Peprotech | 450-10B | Growth factor |
Horse serum | Thermo Fisher Scientific | 16050122 | Media component |
IMDM | Thermo Fisher Scientific | 12440053 | Media component |
Insulin transferrin selenium | Thermo Fisher Scientific | 41400045 | Media component |
Knockout serum replacement | Thermo Fisher Scientific | 10828-028 | Cryopreservation component |
Laminin from Engelbreth-Holm-Swarm murine sarcoma basement membrane | Sigma | L2020-1MG | Coating component and media supplement |
L-glutamine | Thermo Fisher Scientific | 25030-024 | Media component |
N-2 supplement | Thermo Fisher Scientific | 17502-048 | Media component |
Neurobasal medium | Thermo Fisher Scientific | 21103049 | Coating and media component |
Non-essential amino acids | Thermo Fisher Scientific | 11140050 | Media component |
Parafilm M | Sigma | P7793-1EA | Storing equipment |
Penicillin/Streptomycin (5000 U/mL) | Thermo Fisher Scientific | 15070063 | Media component |
Petri dish (3 cm) | nunc | 153066 | Diameter: 3 cm |
Petri dish (10 cm) | Sarstedt | 833.902 | Diameter: 10 cm |
Plate (6-well) | Cellstar Greiner bio-one | 657160 | Culture plate |
Poly-L-ornithine (PLO) | Sigma | P3655-100MG | Coating component |
Retinoic acid | Sigma | R2625 | Media supplement. H302, H315, H360FD, H410. P280. |
Revita cell supplement | Thermo Fisher Scientific | A2644501 | ROCK inhibitor solution |
Smoothened agonist | Merch Millipore | 566660 | Media supplement |
Sodium pyruvate | Life Technologies | 11360-070 | Media component |
T75 flask | Sigma | CLS3276 | Culture plate |
TrypLE express | Thermo Fisher Scientific | 12605010 | MAB dissociation solution |
Tubocyrarine hydrochloride pentahydrate | Sigma | T2379-100G | Acetylcholine receptor blocker. H301. P280. |
XonaChips pre-assembled microfluidic device | Xona Microfluidics | XC150 | Microgroove length: 150 μm |